pharmacy and therapeutics committee drug reviews). Additional limitations include the subjectivity associated with assigned weights of clinical interventions and the use of an average weight for ...

where he oversees the company’s Pharmacy and Therapeutics (P&T) committee, which is responsible for the management and updating of the company’s Intervention Codex, a system of therapeutic ...

where she coordinates and recommends as a voting member of the organization’s Pharmacy and Therapeutics Committee. Prior to her current position, she was co-director of the Illinois Center for ...

Our digital therapeutics and pharmacy services are designed to meet patients where they are, breaking down barriers to recovery. “Participating in the Rx and Illicit Drug Summit is an important ...

PursueCare to Showcase Groundbreaking Digital Therapeutics and Pharmacy Services at Rx and Illicit Drug Summit 2025 in Nashville April 21-24 PursueCare, a leading provider of virtual addiction ...

REVEAL GENOMICS and Ona Therapeutics today announced a strategic collaboration aimed at accelerating the clinical development of ONA-255, a next-generation ADC designed to enhance the precision ...

503A compounded dosage form labeling is also governed by state pharmacy regulations. Accurate compounded product labeling requires attention to detail (i.e., labeling “codeine” is not the same as ...

A bill lawmakers assert is about "personal freedoms" strips pharmacists of the ability to deny certain medications for ...

Unfortunately, what's good news for Eli Lilly is probably bad news for investors in Novo Nordisk and Viking Therapeutics, both of which lag Lilly in the race to develop their own easy-to-take GLP ...

In December, 2021, all 194 Member States of WHO decided to establish the Intergovernmental Negotiating Body (INB) to draft and negotiate a convention, agreement, or other international instrument on ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ ...

RICHMOND, Calif., April 03, 2025--SANGAMO THERAPEUTICS ANNOUNCES CAPSID LICENSE AGREEMENT WITH LILLY TO DELIVER GENOMIC MEDICINES FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM RICHMOND, Calif., ...